Outlook Therapeutics, Inc.

OTLK

Held by 0 specialist biotech funds

Share

Signal Score

0.0/10

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

OTLK is not currently held by any of our tracked specialist biotech funds.

Fund positions update quarterly with new 13F filings. Explore fund convergence to see which tickers multiple funds hold.

No catalysts tracked.

SC 13G/ATang Capital Management3.4%Aug 14, 2025

SC 13G/ATang Capital Management5.6%May 15, 2025

No position data available.

No insider purchases or sales detected in the past 90 days.

Track specialist biotech funds, insider signals, and AI analysis

Get free weekly alerts on fund moves and catalysts: